MediumCardiologyHeart failure with reduced EF first-line therapyau-racpau-amc
A 72 year old man with ischaemic cardiomyopathy (left ventricular ejection fraction 30%) and NYHA class II symptoms is stable on optimal doses of ACE inhibitor and beta blocker. According to Australian heart failure guidelines, which additional class of drug is recommended as part of standard therapy to improve symptoms and prognosis, assuming no contraindication?